»ó´Ü¿©¹é
±â»ç (Àüü 2,389°Ç)
[RTM] ÃÖÀûÀÇ ÀÌ»óÁöÁúÇ÷Áõ °ü¸®¸¦ À§ÇÑ
½ºÅ¸Æ¾/ºñ½ºÅ¸Æ¾ Àü·«ÀÇ ÀÓ»óÀû ¿ªÇÒ
› OPENING REMARKÁÂÀå ³ª½Â¿î ¿À´Ã ¿ù°£ ´õ¸ð½ºÆ®°¡ ÁøÇàÇÏ´Â Á´ãȸ(Round Table Meeting)ÀÇ ÁÂÀå...
THE MOST  |  2024-03-27 17:46
¶óÀÎ
[RTM] ÇÇŸ¹Ù½ºÅ¸Æ¾, ÇÇŸ¹Ù½ºÅ¸Æ¾/¿¡Á¦Æ¼¹Ìºê
ÇÇŸ¹Ù½ºÅ¸Æ¾, ÇÇŸ¹Ù½ºÅ¸Æ¾/¿¡Á¦Æ¼¹Ìºê Clinical KeypointsLDL-C °­ÇÏÈ¿°úÇÇŸ¹Ù½ºÅ¸Æ¾ÀÇ LDL-ÄÝ·¹½ºÅ×·Ñ(LDL-C) °­...
THE MOST  |  2024-03-27 16:34
¶óÀÎ
[RTM] ±¹³» ¸¸¼ºÁúȯ °ü¸®Àü·«ÀÇ ÇöÀç¿Í °úÁ¦
› Lecture I°³¼±µÈ ¸¸¼ºÁúȯ°ü¸® ½Ã¹ü»ç¾÷°ú °Ç°­»ýÈ° ½ÇõÁö¿ø±ÝÁ¦2013³â 11¿ù Áö¿ª»çȸ ÀÏÂ÷ÀÇ·á ½Ã¹ü»ç¾÷¿¡¼­ Ãâ¹ß...
THE MOST  |  2024-03-15 17:35
¶óÀÎ
[Sub Story] Àν¶¸°ºÐºñ´É¡¤Àν¶¸°ÀúÇ×¼º °³¼±±âÀüÀÌ Ã³¹æ½ÃÀå ¾çºÐ
Ç÷´ç°­ÇÏÁ¦ ó¹æ·®¸ÕÀú 2019³â ÇöÀç Ç÷´ç°­ÇÏÁ¦ ´Üµ¶¿ä¹ýÀÇ Ã³¹æ°á°ú¸¦ º¸¸é, ¸ÞÆ®Æ÷¸£¹Î(87.5%)ÀÌ ÀÏ°üµÇ°Ô 1À§ ÀÚ¸®¸¦ °í¼öÇÏ°í ÀÖ...
ÀÌ»óµ· ±âÀÚ  |  2024-03-15 17:04
¶óÀÎ
[Journal Briefing] ¿¬ 2ȸ Åõ¿©, °íÇ÷¾Ð Ä¡·á Æǵµ ¹Ù²ð ¼öµµ
Ç×°íÇ÷¾ÐÁ¦ ½Å¾àÀ¸·Î °³¹ßÁßÀÎ Áú·¹º£½Ã¶õ 1ȸ Åõ¿©·Î Ç÷¾ÐÁ¶Àý È¿°ú°¡ 3°³¿ù ÀÌ»ó Áö¼ÓµÈ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ¸ÅÀÏ ´Ù¾àÁ¦¸¦ º¹¿ëÇؾßÇÏ´Â °íÇ÷¾Ð ȯÀÚ´Â º¹¾à ¼øÀÀµµ°¡ ³·¾Æ ¸ñÇ¥Ç÷¾Ð ´Þ¼º¿¡ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ¾î, Áú·¹º£½Ã...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-03-15 16:57
¶óÀÎ
[Journal Briefing] ÇãÇ÷¼º ³úÁ¹Áß, Ç×Ç÷¼ÒÆÇÁ¦ + Ç×ÀÀ°íÁ¦ Ä¡·á·Î ½Ã³ÊÁö È¿°ú ±â´ë
Á¶±â ½Å°æÇÐÀû ¾ÇÈ­(early neurological deterioration)¸¦ °æÇèÇÑ ±Þ¼º ÇãÇ÷¼º ³úÁ¹Áß È¯ÀÚ¿¡¼­ Ç×ÀÀ°íÁ¦ ¾Æ°¡Æ®·Î¹ÝÀÌ È¯ÀÚÀÇ ½Å°æÇÐÀû ¿¹ÈÄ °³¼±À» ½Ã»çÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. Áß±¹ ÀúÀåÀÇ´ë Min ...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-03-15 16:55
¶óÀÎ
[Interview] ¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°­ÇÏ Ãø¸é¿¡¼­ ACEIÀÇ Æ¯¼ºÀº?ù°, ACEI Ä¡·á°æÇèÀÌ ¾ø´Â ȯÀÚ¿¡°Ô Æ丰µµÇÁ¸±À» Åõ¿©ÇÏ¸é ±âÀú½ÃÁ¡(baseline) ´ëºñ...
ÀÌ»óµ· ±âÀÚ  |  2024-03-15 16:42
¶óÀÎ
[Sub Story] Çѱ¹ÀÎ ¹ÝÀÀ·ü °í·ÁÇϸé Áß°­µµ ÃæºÐÈ÷ È¿°úÀû
µ¿¹ÝÁúȯÀÌ»óÁöÁúÇ÷ÁõÀº ´ç´¢º´ ȯÀÚÀÇ ´ëÇ÷°üÇÕº´Áõ ¿¹¹æÀ» À§ÇØ ¹Ýµå½Ã Àâ¾Æ¾ß ÇÏ´Â ½ÉÇ÷°üÁúȯ À§ÇèÀÎÀÚ Áß Çϳª·Î Áö¸ñµÇ°í ÀÖ´Ù. ±× ¸¸Å­...
ÀÌ»óµ· ±âÀÚ  |  2024-03-15 16:24
¶óÀÎ
[Journal Briefing] Ç÷´ç°­ÇÏÁ¦ º´¿ë, ½ÉÇ÷°ü¡¤½ÅÀå ÇýÅà ½Ã»ç
Ç÷´ç°­ÇÏÁ¦ º´¿ë¿ä¹ýÀÌ Áß°­µµ ÀÌ»óÀÇ ´Ü¹é´¢¸¦ µ¿¹ÝÇÑ 2Çü´ç´¢º´ ȯÀÚ¿¡¼­ ½ÉÇ÷°ü¡¤½ÅÀå ÇýÅðú ¿¬°ü¼ºÀ» º¸¿´´Ù´Â ¿¬±¸°á°ú°¡ Circulation¿¡ °ÔÀçµÆ´Ù. ¹Ì±¹ ÇϹöµåÀÇ´ë Muthiah Vaduganathan ±³¼öÆÀÀº...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-03-15 15:44
¶óÀÎ
[Journal Briefing] ´ÙÆı۸®Ç÷ÎÁø ¸®¾ó¿ùµå¿¡¼­µµ ½ÅÀåÇýÅà °Åµì È®ÀÎ
´ÙÆı۸®Ç÷ÎÁø Ä¡·á°¡ ¾ËºÎ¹Î´¢¸¦ µ¿¹ÝÇÑ 2Çü´ç´¢º´ ȯÀÚÀÇ ½ÅÀå±â´É ¾Æ¿ôÄÄÀ» °³¼±½ÃÄ×´Ù´Â ¿¬±¸°á°ú°¡ ¹ßÇ¥µÆ´Ù. ÀÌ´Â DARWIN-RenalÀÇ Èļӿ¬±¸ °á°ú·Î, ´ÙÆı۸®Ç÷ÎÁø°ú ´Ù¸¥ Ç÷´ç°­ÇÏÁ¦ Åõ¿©½Ã ½ÅÀå ¾Æ¿ôÄÄÀ» Àå±â...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-03-15 15:42
¶óÀÎ
[Interview] ¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿­È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â?´çÈ­Ç÷»ö¼Ò(A1C)¿¡ ±Ù°ÅÇÑ SGLT-2¾ïÁ¦Á¦(SGLT-2i)ÀÇ Ç÷´çÁ¶Àý È¿°ú¿¡ ´ëÇØ ±¹³»...
ÀÌ»óµ· ±âÀÚ  |  2024-03-15 15:30
¶óÀÎ
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ý
¡â´Ù¾çÇÑ º´Å»ý¸®¡â¸ñÇ¥Ç÷¾Ð °­È­¿¡¼­ ±âÀÎ
´Ù¾çÇÑ º´Å»ý¸®Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ýÀÇ ÀÌ·ÐÀû ¹è°æÀº °íÇ÷¾ÐÀÇ º´Å»ý¸®¿¡¼­ ´äÀ» ãÀ» ¼ö ÀÖ´Ù. °íÇ÷¾ÐÀº RAS(·¹´Ñ¡¤¾ÈÁö¿ÀÅٽŽýºÅÛ)¾ïÁ¦...
ÀÌ»óµ· ±âÀÚ  |  2024-03-14 17:57
¶óÀÎ
[Interview] ¡°°í°­µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈ­ÇÐȸ Áø·áÁöħ¿¡¼­ °ü»óµ¿¸ÆÁúȯ(CAD) º´·ÂÀÚÀÇ LDLÄÝ·¹½ºÅ×·Ñ(LDL-C)...
ÀÌ»óµ· ±âÀÚ  |  2024-03-14 17:41
¶óÀÎ
[Clinical Update] NAFLD & ºñ¸¸¡¤´ç´¢º´ µ¿¹ÝÀÌȯ °¡´É¼º Çö½Ç·Î
¹ß»ý·ü´ëÇÑ°£ÇÐȸÀÇ °£Áúȯ¹é¼­(2023³â)¿¡ µû¸£¸é, ¿¬±¸¹æ¹ý°ú Áø´Ü±âÁØ¿¡ µû¶ó Â÷À̸¦ º¸ÀÌÁö¸¸ NAFLD ¹ß»ý·üÀº 1000¸í´ç ¿¬°£ 2...
ÀÌ»óµ· ±âÀÚ  |  2024-03-13 15:20
¶óÀÎ
[Drug Review] ÄÉ·»µð¾ÆÁ¤ Çã°¡¡¤±Þ¿©·Î
2Çü´ç´¢º´ µ¿¹Ý ¸¸¼º½ÅÀ庴 Ä¡·á ¿ÏÀüü °¡µ¿
2Çü´ç´¢º´ µ¿¹Ý ¸¸¼º½ÅÀ庴¸¸¼º½ÅÀåÁúȯ(CKD, chronic kidney disease)Àº ¼Òº¯ ¾ËºÎ¹Î ¼öÄ¡(UACR, ¾ËºÎ¹Î-Å©·¹¾ÆƼ...
ÀÌ»óµ· ±âÀÚ  |  2024-03-13 14:56
¶óÀÎ
[Sub Story] Ç×°íÇ÷¾ÐÁ¦+½ºÅ¸Æ¾ º´¿ëÄ¡·á´Â ±Ù°ÅÁß½ÉÀÇÇÐ ´ëÇ¥»ç·Ê
´ë»çÁõÈıº°íÇ÷¾ÐÀÌ ÀÌ»óÁöÁúÇ÷Áõ ¿Ü¿¡µµ °íÇ÷´ç¡¤º¹ºÎºñ¸¸ µî ¿©Å¸ ½ÉÇ÷°üÁúȯ À§ÇèÀÎÀÚ¿Í µ¿¹ÝµÅ »óÈ£ÀÛ¿ëÇÏ¸ç ½ÉÇ÷°üÁúȯ À§ÇèÀ» ´õ Áõ°¡½ÃŲ´Ù...
ÀÌ»óµ· ±âÀÚ  |  2024-03-13 14:48
¶óÀÎ
[Late Breaking Studies] ÇÇŸ¹Ù½ºÅ¸Æ¾, Á׻󵿸ưæÈ­Áõ ÅðÇà °¡´É¼º ½Ã»ç
REPRIEVE ÇÏÀ§ºÐ¼®À̹ø ÇÏÀ§ºÐ¼®Àº 2015~2018³â ¹Ì±¹ 31°³ ¿¬±¸±â°ü¿¡¼­ ÁøÇàµÈ ¹«ÀÛÀ§¡¤´ëÁ¶±º ÀÓ»ó½ÃÇèÀÎ REPRIEVE ¸ð...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-03-13 14:32
¶óÀÎ
[Interview] ¡°1Â÷ÀÇ·á ´Ü°è¼­ºÎÅÍ ´ç´¢º´¼º ½ÅÀåÁúȯ ½Ï ã¾Æ³» À߶ó³»ÀÚ¡±
Q. °¡À̵å¶óÀο¡¼­ SGLT-2i´Â ¾î¶»°Ô ±Ç°íµÇ³ª?´ëÇÑ´ç´¢º´ÇÐȸ Áø·áÁöħ¿¡¼­´Â ´çÈ­Ç÷»ö¼Ò(A1C) ¼öÄ¡¿¡ ±Ù°ÅÇÏ´Â ¡âÇ÷´çÁ¶Àý »Ó ¾Æ´Ï...
ÀÌ»óµ· ±âÀÚ  |  2024-03-13 14:15
¶óÀÎ
[Sub Story] Çѱ¹ÀÎ ´ç´¢º´ º´Å»ý¸®´Â ºñºö¹äÇü
Àν¶¸°ºÐºñ´É2Çü´ç´¢º´ º´Å»ý¸®ÀÇ ´Ù¾ç¼º¿¡ µû¶ó Àν¶¸°ÀúÇ×¼ºÀº ¹°·Ð Àν¶¸°ºÐºñ´ÉÀ» °³¼±ÇÏ´Â ±âÀüÀÇ ¾àÁ¦±îÁö ¾î´À °Í Çϳª °£°úÇÒ ¼ö ¾ø´Ù...
ÀÌ»óµ· ±âÀÚ  |  2024-03-12 15:41
¶óÀÎ
[Sub Story] ½ºÅ¸Æ¾, ½ÉÇ÷°üÁúȯ 2Â÷¿¹¹æ¿¡ ±â¿©
100mg/dL → 70mg/dLÁö±ÝÀÌ¾ß 55mg/dL ¹Ì¸¸±îÁö ³»·Á¿ÔÁö¸¸, ½ÉÇ÷°üÁúȯ º´·ÂÀÚ µî ÃÊ°íÀ§Ç豺ÀÇ 2Â÷¿¹¹æÀ» À§ÇØ...
ÀÌ»óµ· ±âÀÚ  |  2024-03-12 14:52
Back to Top